Showing results (241-250 of 323) with videos related to
Sort By:
Pageof 33
Bioorganic & Medicinal Chemistry Letters|January 14, 2020
Benzopyrimidodiazepinone inhibitors of TNK2Brian J Groendyke, Chelsea E Powell, Frederic Feru, et al.Science (New York, N.Y.)|June 21, 2008
Modulation of gene expression via disruption of NF-kappaB signaling by a bacterial small moleculeVladimir V Kravchenko, Gunnar F Kaufmann, John C Mathison, et al.The Biochemical Journal|July 31, 2020
An acidic residue buried in the dimer interface of isocitrate dehydrogenase 1 (IDH1) helps regulate catalysis and pH sensitivityLucas A Luna, Zachary Lesecq, Katharine A White, et al.Biorxiv : the Preprint Server for Biology|December 16, 2024
Macropinocytosis controls metabolic stress-driven CAF subtype identity in pancreatic cancerYijuan Zhang, Li Ling, Swetha Maganti, et al.Mbio|April 19, 2018
Microbiota and Metatranscriptome Changes Accompanying the Onset of GingivitisEmily M Nowicki, Raghav Shroff, Jacqueline A Singleton, et al.Acta Biomaterialia|May 25, 2020
Host macrophage response to injectable hydrogels derived from ECM and α-helical peptidesNazia Mehrban, Catalina Pineda Molina, Lina M Quijano, et al.ANZ Journal of Surgery|November 24, 2020
COVID-19 risk in elective surgery during a second wave: a prospective cohort studyPaul S Myles, Sophie Wallace, David A Story, et al.Mbio|February 20, 2014
Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteriaIrina A Rodionova, Brian M Schuster, Kristine M Guinn, et al.Cell|March 10, 2015
Genome-wide CRISPR screen in a mouse model of tumor growth and metastasisSidi Chen, Neville E Sanjana, Kaijie Zheng, et al.The Biochemical Journal|September 26, 2018
Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutantsDiego Avellaneda Matteo, Grace A Wells, Lucas A Luna, et al.Pageof 33